ATEA PHARMACEUTICALS INC (AVIR) Stock Balance Sheet
NASDAQ:AVIR - Nasdaq - US04683R1068 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 119.39M | 64.70M | 143.82M | 188.50M | 764.40M | |||
| Marketable Securities | 306.04M | 390.02M | 434.28M | 458.20M | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 8.27M | 7.63M | 12.35M | 14.20M | 8.00M | |||
| Total Current Assets | 433.71M | 462.36M | 590.46M | 660.90M | 772.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.86M | 2.12M | 3.12M | 4.10M | 200.00K | |||
| Other Non-Current Assets | 4.39M | 197.00K | 1.40M | 1.70M | 300.00K | |||
| Total Non-Current Assets | 6.26M | 2.31M | 4.51M | 5.80M | 500.00K | |||
| TOTAL ASSETS | 439.96M | 464.67M | 594.97M | 666.70M | 772.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 14.36M | 14.14M | 28.12M | 15.80M | 49.80M | |||
| Accounts Payable | 7.39M | 4.46M | 4.25M | 2.60M | 4.50M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 100.00K | 2.60M | |||
| Total Current Liabilities | 21.75M | 18.60M | 32.38M | 18.50M | 56.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 7.13M | 7.20M | 7.40M | 7.70M | 5.90M | |||
| Total Non-Current Liabilities | 7.13M | 7.20M | 7.40M | 7.60M | 5.90M | |||
| TOTAL LIABILITIES | 28.88M | 25.80M | 39.78M | 26.10M | 62.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -398.49M | -364.22M | -195.84M | -59.90M | 56.00M | |||
| Additional Paid In Capital | 809.37M | 802.77M | 750.74M | 701.10M | 654.00M | |||
| Common Shares | 85.00K | 84.00K | 83.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 118.00K | 233.00K | 207.00K | -700.00K | N/A | |||
| Shares Outstanding | 85.58M | 84.46M | 83.44M | 83.30M | 83.10M | |||
| Tangible Book Value per Share | 4.80 | 5.20 | 6.65 | 7.69 | 8.55 | |||
| Total Shareholders' Equity | 411.08M | 438.87M | 555.19M | 640.60M | 710.10M | |||
| TOTAL LIABILITIES AND EQUITY | 439.96M | 464.67M | 594.97M | 666.70M | 772.90M | |||
| Statistics | ||||||||
| Current Ratio | 19.94 | 24.85 | 18.24 | 35.72 | 13.57 | |||
| Return On Assets (ROA) | -31.81% | -36.15% | -22.86% | -17.38% | 15.68% | |||
| Return On Equity (ROE) | -34.05% | -38.28% | -24.50% | -18.09% | 17.07% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 25.59% | |||
All data in USD , ROIC based on taxRate of 0.21